Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative disease

Ageing Research Reviews

Volumn 32, Issue , 2016, Pages 75-88

  Colacurcio, Daniel J ^a,b   Nixon, Ralph A ^a,b,c  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acidification; Alzheimer's disease; Autophagy; Calcium; Caloric restriction; Cathepsin; Endocytosis; Lysosomal storage disease; Lysosome; mTORC; Parkinson's disease; pH; TFEB; v ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM; UNCLASSIFIED DRUG; VACUOLAR ATPASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ACIDIFICATION; AGING; CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; ENZYME REGULATION; GENE MUTATION; HOMEOSTASIS; HUMAN; HYDROLYSIS; LYSOSOME; LYSOSOME STORAGE DISEASE; NONHUMAN; PARKINSON DISEASE; REVIEW; AUTOPHAGY; CALORIC RESTRICTION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; AUTOPHAGY; CALORIC RESTRICTION; HUMANS; LYSOSOMES; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84971643966     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.05.004     Document Type: Review

References (239)

1. Allanson, J., Austin, W., Hecht, F., Congenital cutis laxa with retardation of growth and motor development: a recessive disorder of connective tissue with male lethality. Clin. Genet. 29 (1986), 133–136.
2. Asano, T., Komatsu, M., Yamaguchi-Iwai, Y., Ishikawa, F., Mizushima, N., Iwai, K., Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol. Cell. Biol. 31 (2011), 2040–2052.
3. Avrahami, L., Farfara, D., Shaham-Kol, M., Vassar, R., Frenkel, D., Eldar-Finkelman, H., Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies. J. Biol. Chem. 288 (2013), 1295–1306.
4. Ballabio, A., Gieselmann, V., Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta 1793 (2009), 684–696.
5. Baltazar, G.C., Guha, S., Lu, W., Lim, J., Boesze-Battaglia, K., Laties, A.M., Tyagi, P., Kompella, U.B., Mitchell, C.H., Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells. PLoS One, 7, 2012, e49635.
6. Barone, E., Editorial: oxidative stress and Alzheimer disease: where do we stand?. Curr. Alzheimer Res. 13 (2016), 108–111.
7. Behrends, C., Sowa, M.E., Gygi, S.P., Harper, J.W., Network organization of the human autophagy system. Nature 466 (2010), 68–76.
8. Belinson, H., Lev, D., Masliah, E., Michaelson, D.M., Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J. Neurosci. 28 (2008), 4690–4701.
9. Bergmann, M., Schutt, F., Holz, F.G., Kopitz, J., Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 18 (2004), 562–564.
10. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000), 1301–1306.
11. Bhargava, A., Voronov, I., Wang, Y., Glogauer, M., Kartner, N., Manolson, M.F., Osteopetrosis mutation R444L causes endoplasmic reticulum retention and misprocessing of vacuolar H+-ATPase a3 subunit. J. Biol. Chem. 287 (2012), 26829–26839.
12. Blake-Palmer, K.G., Karet, F.E., Cellular physiology of the renal H + ATPase. Curr. Opin. Nephrol. Hypertens. 18 (2009), 433–438.
13. Boland, B., Platt, F.M., Bridging the age spectrum of neurodegenerative storage diseases. Best Pract. Res. Clin. Endocrinol. Metab. 29 (2015), 127–143.
14. Boland, B., Kumar, A., Lee, S., Platt, F.M., Wegiel, J., Yu, W.H., Nixon, R.A., Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 28 (2008), 6926–6937.
15. Bourdenx, M., Daniel, J., Genin, E., Soria, F.N., Blanchard-Desce, M., Bezard, E., Dehay, B., Nanoparticles restore lysosomal acidification defects: implications for Parkinson and other lysosomal-related diseases. Autophagy 12 (2016), 472–483.
16. Braccini, L., Ciraolo, E., Campa, C.C., Perino, A., Longo, D.L., Tibolla, G., Pregnolato, M., Cao, Y., Tassone, B., Damilano, F., et al. PI3K-C2gamma is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling. Nat. Commun., 6, 2015, 7400.
17. Bras, J., Verloes, A., Schneider, S.A., Mole, S.E., Guerreiro, R.J., Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet. 21 (2012), 2646–2650.
18. Bras, J., Guerreiro, R., Darwent, L., Parkkinen, L., Ansorge, O., Escott-Price, V., Hernandez, D.G., Nalls, M.A., Clark, L.N., Honig, L.S., et al. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum. Mol. Genet. 23 (2014), 6139–6146.
19. Breton, S., Brown, D., Regulation of luminal acidification by the V-ATPase. Physiology (Bethesda) 28 (2013), 318–329.
20. Butler, D., Hwang, J., Estick, C., Nishiyama, A., Kumar, S.S., Baveghems, C., Young-Oxendine, H.B., Wisniewski, M.L., Charalambides, A., Bahr, B.A., Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One, 6, 2011, e20501.
21. Butterfield, D.A., Sultana, R., Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J. Alzheimers Dis. 12 (2007), 61–72.
22. Butterfield, D.A., Di Domenico, F., Swomley, A.M., Head, E., Perluigi, M., Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain. Biochem. J 463 (2014), 177–189.
23. Butterfield, D.A., Gu, L., Di Domenico, F., Robinson, R.A., Mass spectrometry and redox proteomics: applications in disease. Mass Spectrom. Rev. 33 (2014), 277–301.
24. Callaghan, R.C., Cunningham, J.K., Sykes, J., Kish, S.J., Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 120 (2012), 35–40.
25. Cataldo, A.M., Peterhoff, C.M., Troncoso, J.C., Gomez-Isla, T., Hyman, B.T., Nixon, R.A., Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157 (2000), 277–286.
26. Chang, S.H., Jung, I.S., Han, G.Y., Kim, N.H., Kim, H.J., Kim, C.W., Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 430 (2013), 670–675.
27. Chen, C.M., Lin, C.H., Juan, H.F., Hu, F.J., Hsiao, Y.C., Chang, H.Y., Chao, C.Y., Chen, I.C., Lee, L.C., Wang, T.W., et al. ATP13A2 variability in Taiwanese Parkinson's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B (2011), 720–729.
28. Chen, J.J., Li, Y.M., Zou, W.Y., Fu, J.L., Relationships between CETP genetic polymorphisms and Alzheimer's disease risk: a meta-analysis. DNA Cell Biol. 33 (2014), 807–815.
29. Chen, X., Hui, L., Geiger, J.D., Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease. J. Neurol. Neurophysiol., 5, 2014.
30. Christensen, K.A., Myers, J.T., Swanson, J.A., pH-dependent regulation of lysosomal calcium in macrophages. J. Cell Sci. 115 (2002), 599–607.
31. Chung, J.H., Lester, R.L., Dickson, R.C., Sphingolipid requirement for generation of a functional v1 component of the vacuolar ATPase. J. Biol. Chem. 278 (2003), 28872–28881.
32. Coen, K., Flannagan, R.S., Baron, S., Carraro-Lacroix, L.R., Wang, D., Vermeire, W., Michiels, C., Munck, S., Baert, V., Sugita, S., et al. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 198 (2012), 23–35.
33. Coffey, E.E., Beckel, J.M., Laties, A.M., Mitchell, C.H., Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 263 (2014), 111–124.
34. Cotter, K., Stransky, L., McGuire, C., Forgac, M., Recent insights into the structure regulation, and function of the V-ATPases. Trends Biochem. Sci. 40 (2015), 611–622.
35. Coutinho, M.F., Alves, S., From rare to common and back again: 60years of lysosomal dysfunction. Mol. Genet. Metab. 117:February(2) (2016), 53–65.
36. Cox, B.E., Griffin, E.E., Ullery, J.C., Jerome, W.G., Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification. J. Lipid Res. 48 (2007), 1012–1021.
37. Crider, B.P., Xie, X.S., Characterization of the functional coupling of bovine brain vacuolar-type H(+)-translocating ATPase Effect of divalent cations, phospholipids, and subunit H (SFD). J. Biol. Chem. 278 (2003), 44281–44288.
38. Cubells, J.F., Rayport, S., Rajendran, G., Sulzer, D., Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14 (1994), 2260–2271.
39. Cuervo, A.M., Dice, J.F., Age-related decline in chaperone-mediated autophagy. J. Biol. Chem. 275 (2000), 31505–31513.
40. Cuervo, A.M., Dice, J.F., When lysosomes get old. Exp. Gerontol. 35 (2000), 119–131.
41. Cuervo, A.M., Wong, E., Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 24 (2014), 92–104.
42. Cuervo, A.M., Stefanis, L., Fredenburg, R., Lansbury, P.T., Sulzer, D., Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 (2004), 1292–1295.
43. Curtin, K., Fleckenstein, A.E., Robison, R.J., Crookston, M.J., Smith, K.R., Hanson, G.R., Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend. 146 (2015), 30–38.
44. D'Souza, R.S., Levandowski, C., Slavov, D., Graw, S.L., Allen, L.A., Adler, E., Mestroni, L., Taylor, M.R., Danon disease: clinical features, evaluation, and management. Circ. Heart Fail 7 (2014), 843–849.
45. Dauer, W., Przedborski, S., Parkinson's disease: mechanisms and models. Neuron 39 (2003), 889–909.
46. Decressac, M., Mattsson, B., Weikop, P., Lundblad, M., Jakobsson, J., Bjorklund, A., TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E1817–1826.
47. Dehay, B., Martinez-Vicente, M., Ramirez, A., Perier, C., Klein, C., Vila, M., Bezard, E., Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 8 (2012), 1389–1391.
48. Dehay, B., Ramirez, A., Martinez-Vicente, M., Perier, C., Canron, M.H., Doudnikoff, E., Vital, A., Vila, M., Klein, C., Bezard, E., Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 9611–9616.
49. Dehay, B., Martinez-Vicente, M., Caldwell, G.A., Caldwell, K.A., Yue, Z., Cookson, M.R., Klein, C., Vila, M., Bezard, E., Lysosomal impairment in Parkinson's disease. Mov. Disord. 28 (2013), 725–732.
50. Deng, H., Xiu, X., Jankovic, J., Genetic convergence of Parkinson's disease and lysosomal storage disorders. Mol. Neurobiol. 51 (2015), 1554–1568.
51. Di Domenico, F., Perluigi, M., Butterfield, D.A., Cornelius, C., Calabrese, V., Oxidative damage in rat brain during aging: interplay between energy and metabolic key target proteins. Neurochem. Res. 35 (2010), 2184–2192.
52. Di Domenico, F., Sultana, R., Ferree, A., Smith, K., Barone, E., Perluigi, M., Coccia, R., Pierce, W., Cai, J., Mancuso, C., et al. Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. Antioxid. Redox Signal. 17 (2012), 1490–1506.
53. Di Fonzo, A., Chien, H.F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Marconi, R., Fincati, E., Abbruzzese, G., et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68 (2007), 1557–1562.
54. Djarmati, A., Hagenah, J., Reetz, K., Winkler, S., Behrens, M.I., Pawlack, H., Lohmann, K., Ramirez, A., Tadic, V., Bruggemann, N., et al. ATP13A2 variants in early-onset Parkinson's disease patients and controls. Mov. Disord. 24 (2009), 2104–2111.
55. Dobrowolski, R., Vick, P., Ploper, D., Gumper, I., Snitkin, H., Sabatini, D.D., De Robertis, E.M., Presenilin deficiency or lysosomal inhibition enhances Wnt signaling through relocalization of GSK3 to the late-endosomal compartment. Cell Rep. 2 (2012), 1316–1328.
56. Dubos, A., Castells-Nobau, A., Meziane, H., Oortveld, M.A., Houbaert, X., Iacono, G., Martin, C., Mittelhaeuser, C., Lalanne, V., Kramer, J.M., et al. Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration. Hum. Mol. Genet. 24 (2015), 6736–6755.
57. Efeyan, A., Zoncu, R., Sabatini, D.M., Amino acids and mTORC1: from lysosomes to disease. Trends Mol. Med. 18 (2012), 524–533.
58. Einhorn, Z., Trapani, J.G., Liu, Q., Nicolson, T., Rabconnectin3alpha promotes stable activity of the H+ pump on synaptic vesicles in hair cells. J. Neurosci. 32 (2012), 11144–11156.
59. Emre, M., Aarsland, D., Brown, R., Burn, D.J., Duyckaerts, C., Mizuno, Y., Broe, G.A., Cummings, J., Dickson, D.W., Gauthier, S., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22 (2007), 1689–1707 (quiz 1837).
60. Farias, F.H., Zeng, R., Johnson, G.S., Wininger, F.A., Taylor, J.F., Schnabel, R.D., McKay, S.D., Sanders, D.N., Lohi, H., Seppala, E.H., et al. A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiol. Dis. 42 (2011), 468–474.
61. Felbor, U., Kessler, B., Mothes, W., Goebel, H.H., Ploegh, H.L., Bronson, R.T., Olsen, B.R., Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 7883–7888.
62. Finnigan, G.C., Ryan, M., Stevens, T.H., A genome-wide enhancer screen implicates sphingolipid composition in vacuolar ATPase function in Saccharomyces cerevisiae. Genetics 187 (2011), 771–783.
63. Fiorini, A., Sultana, R., Forster, S., Perluigi, M., Cenini, G., Cini, C., Cai, J., Klein, J.B., Farr, S.A., Niehoff, M.L., et al. Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study. Free Radic. Biol. Med. 65 (2013), 1–14.
64. Forgac, M., Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8 (2007), 917–929.
65. Frake, R.A., Ricketts, T., Menzies, F.M., Rubinsztein, D.C., Autophagy and neurodegeneration. J. Clin. Invest. 125 (2015), 65–74.
66. Fry, A.C., Karet, F.E., Inherited renal acidoses. Physiology (Bethesda) 22 (2007), 202–211.
67. Fu, Y., Zhao, D., Pan, B., Wang, J., Cui, Y., Shi, F., Wang, C., Yin, X., Zhou, X., Yang, L., Proteomic analysis of protein expression throughout disease progression in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 47 (2015), 915–926.
68. Fujisawa, Y., Kato, K., Giulivi, C., Nitration of tyrosine residues 368 and 345 in the beta-subunit elicits FoF1-ATPase activity loss. Biochem. J 423 (2009), 219–231.
69. Funakoshi-Hirose, I., Aki, T., Unuma, K., Funakoshi, T., Noritake, K., Uemura, K., Distinct effects of methamphetamine on autophagy-lysosome and ubiquitin-proteasome systems in HL-1 cultured mouse atrial cardiomyocytes. Toxicology 312 (2013), 74–82.
70. Futerman, A.H., van Meer, G., The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5 (2004), 554–565.
71. Gan-Or, Z., Dion, P.A., Rouleau, G.A., Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease. Autophagy 11 (2015), 1443–1457.
72. Genis, D., Davalos, A., Molins, A., Ferrer, I., Wolfram syndrome: a neuropathological study. Acta Neuropathol. 93 (1997), 426–429.
73. Gharanei, S., Zatyka, M., Astuti, D., Fenton, J., Sik, A., Nagy, Z., Barrett, T.G., Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability. Hum. Mol. Genet. 22 (2013), 203–217.
74. Ginsberg, S.D., Alldred, M.J., Counts, S.E., Cataldo, A.M., Neve, R.L., Jiang, Y., Wuu, J., Chao, M.V., Mufson, E.J., Nixon, R.A., et al. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol. Psychiatry 68 (2010), 885–893.
75. Gitler, A.D., Chesi, A., Geddie, M.L., Strathearn, K.E., Hamamichi, S., Hill, K.J., Caldwell, K.A., Caldwell, G.A., Cooper, A.A., Rochet, J.C., et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41 (2009), 308–315.
76. Gotzl, J.K., Mori, K., Damme, M., Fellerer, K., Tahirovic, S., Kleinberger, G., Janssens, J., van der Zee, J., Lang, C.M., Kremmer, E., et al. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol. 127 (2014), 845–860.
77. Guicciardi, M.E., Leist, M., Gores, G.J., Lysosomes in cell death. Oncogene 23 (2004), 2881–2890.
78. Guillard, M., Dimopoulou, A., Fischer, B., Morava, E., Lefeber, D.J., Kornak, U., Wevers, R.A., Vacuolar H+-ATPase meets glycosylation in patients with cutis laxa. Biochim. Biophys. Acta 1792 (2009), 903–914.
79. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006), 885–889.
80. Harris, H., Rubinsztein, D.C., Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8 (2012), 108–117.
81. Hatanaka, M., Tanabe, K., Yanai, A., Ohta, Y., Kondo, M., Akiyama, M., Shinoda, K., Oka, Y., Tanizawa, Y., Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic beta-cells. Hum. Mol. Genet. 20 (2011), 1274–1284.
82. Haynes, V., Traaseth, N.J., Elfering, S., Fujisawa, Y., Giulivi, C., Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging. Am. J. Physiol. Endocrinol. Metab. 298 (2010), E978–987.
83. He, C., Klionsky, D.J., Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43 (2009), 67–93.
84. Hedera, P., Alvarado, D., Beydoun, A., Fink, J.K., Novel mental retardation-epilepsy syndrome linked to Xp21.1-p11.4. Ann. Neurol. 51 (2002), 45–50.
85. Hennings, J.C., Picard, N., Huebner, A.K., Stauber, T., Maier, H., Brown, D., Jentsch, T.J., Vargas-Poussou, R., Eladari, D., Hubner, C.A., A mouse model for distal renal tubular acidosis reveals a previously unrecognized role of the V-ATPase a4 subunit in the proximal tubule. EMBO Mol. Med. 4 (2012), 1057–1071.
86. Henry, A.G., Aghamohammadzadeh, S., Samaroo, H., Chen, Y., Mou, K., Needle, E., Hirst, W.D., Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum. Mol. Genet. 24 (2015), 6013–6028.
87. Hughes, A.L., Gottschling, D.E., An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast. Nature 492 (2012), 261–265.
88. Hui, L., Chen, X., Geiger, J.D., Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons. Life Sci. 91 (2012), 1159–1168.
89. Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., Mueckler, M., Marshall, H., Donis-Keller, H., Crock, P., et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20 (1998), 143–148.
90. Ivy, G.O., Kanai, S., Ohta, M., Smith, G., Sato, Y., Kobayashi, M., Kitani, K., Lipofuscin-like substances accumulate rapidly in brain, retina and internal organs with cysteine protease inhibition. Adv. Exp. Med. Biol. 266 (1989), 31–45 discussion 45–37.
91. Ji, Z.-S.S., Miranda, R.D., Newhouse, Y.M., Weisgraber, K.H., Huang, Y., Mahley, R.W., Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem. 277 (2002), 21821–21828.
92. Ji, Z.-S.S., Müllendorff, K., Cheng, I.H., Miranda, R.D., Huang, Y., Mahley, R.W., Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J. Biol. Chem. 281 (2006), 2683–2692.
93. Johnson, D.E., Ostrowski, P., Jaumouille, V., Grinstein, S., The position of lysosomes within the cell determines their luminal pH. J. Cell Biol. 212 (2016), 677–692.
94. Kalinderi, K., Bostantjopoulou, S., Fidani, L., The genetic background of Parkinson's disease: current progress and future prospects. Acta Neurol. Scand., 2016, 10.1111/ane.12563 [Epub ahead of print].
95. Kane, P.M., Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivo. J. Biol. Chem. 270 (1995), 17025–17032.
96. Karet, F.E., Finberg, K.E., Nayir, A., Bakkaloglu, A., Ozen, S., Hulton, S.A., Sanjad, S.A., Al-Sabban, E.A., Medina, J.F., Lifton, R.P., Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34. Am. J. Hum. Genet. 65 (1999), 1656–1665.
97. Karet, F.E., Finberg, K.E., Nelson, R.D., Nayir, A., Mocan, H., Sanjad, S.A., Rodriguez-Soriano, J., Santos, F., Cremers, C.W., Di Pietro, A., et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 21 (1999), 84–90.
98. Kawamura, N., Tabata, H., Sun-Wada, G.H., Wada, Y., Optic nerve compression and retinal degeneration in Tcirg1 mutant mice lacking the vacuolar-type H-ATPase a3 subunit. PLoS One, 5, 2010, e12086.
99. Keith, C.G., Retinal atrophy in osteopetrosis. Arch. Ophthalmol. 79 (1968), 234–241.
100. Kett, L.R., Stiller, B., Bernath, M.M., Tasset, I., Blesa, J., Jackson-Lewis, V., Chan, R.B., Zhou, B., Di Paolo, G., Przedborski, S., et al. alpha-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. J Neurosci 35 (2015), 5724–5742.
101. Kettner, C., Bertl, A., Obermeyer, G., Slayman, C., Bihler, H., Electrophysiological analysis of the yeast V-type proton pump: variable coupling ratio and proton shunt. Biophys J 85 (2003), 3730–3738.
102. Kiffin, R., Bandyopadhyay, U., Cuervo, A.M., Oxidative stress and autophagy. Antioxid. Redox Signal. 8 (2006), 152–162.
103. Kim, S., Sato, Y., Mohan, P.S., Peterhoff, C., Pensalfini, A., Rigoglioso, A., Jiang, Y., Nixon, R.A., Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease. Mol Psychiatry. 21:May(5) (2016), 707–716.
104. Kinouchi, K., Ichihara, A., Sano, M., Sun-Wada, G.H., Wada, Y., Kurauchi-Mito, A., Bokuda, K., Narita, T., Oshima, Y., Sakoda, M., et al. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res 107 (2010), 30–34.
105. Kinouchi, K., Ichihara, A., Itoh, H., Functional characterization of (pro)renin receptor in association with V-ATPase. Front. Biosci. (Landmark Ed.) 16 (2011), 3216–3223.
106. Kinouchi, K., Ichihara, A., Sano, M., Sun-Wada, G.H., Wada, Y., Ochi, H., Fukuda, T., Bokuda, K., Kurosawa, H., Yoshida, N., et al. The role of individual domains and the significance of shedding of ATP6AP2/(pro)renin receptor in vacuolar H(+)-ATPase biogenesis. PLoS One, 8, 2013, e78603.
107. Klionsky, D.J., Codogno, P., Cuervo, A.M., Deretic, V., Elazar, Z., Fueyo-Margareto, J., Gewirtz, D.A., Kroemer, G., Levine, B., Mizushima, N., et al. A comprehensive glossary of autophagy-related molecules and processes. Autophagy 6 (2010), 438–448.
108. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006), 880–884.
109. Kornak, U., Schulz, A., Friedrich, W., Uhlhaas, S., Kremens, B., Voit, T., Hasan, C., Bode, U., Jentsch, T.J., Kubisch, C., Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9 (2000), 2059–2063.
110. Kornak, U., Reynders, E., Dimopoulou, A., van Reeuwijk, J., Fischer, B., Rajab, A., Budde, B., Nurnberg, P., Foulquier, F., Group, A.D.-t.S., et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet 40 (2008), 32–34.
111. Kortum, F., Caputo, V., Bauer, C.K., Stella, L., Ciolfi, A., Alawi, M., Bocchinfuso, G., Flex, E., Paolacci, S., Dentici, M.L., et al. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome. Nat. Genet. 47 (2015), 661–667.
112. Korvatska, O., Strand, N.S., Berndt, J.D., Strovas, T., Chen, D.H., Leverenz, J.B., Kiianitsa, K., Mata, I.F., Karakoc, E., Greenup, J.L., et al. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). Hum. Mol. Genet. 22 (2013), 3259–3268.
113. Kukic, I., Kelleher, S.L., Kiselyov, K., Zn2+ efflux through lysosomal exocytosis prevents Zn2+-induced toxicity. J. Cell Sci. 127 (2014), 3094–3103.
114. Kurz, T., Terman, A., Gustafsson, B., Brunk, U.T., Lysosomes and oxidative stress in aging and apoptosis. Biochim. Biophys. Acta 1780 (2008), 1291–1303.
115. Kurz, T., Eaton, J.W., Brunk, U.T., Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid. Redox Signal. 13 (2010), 511–523.
116. Lee, J.-H.H., Yu, W.H., Kumar, A., Lee, S., Mohan, P.S., Peterhoff, C.M., Wolfe, D.M., Martinez-Vicente, M., Massey, A.C., Sovak, G., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141 (2010), 1146–1158.
117. Lee, J.H., Yu, W.H., Kumar, A., Lee, S., Mohan, P.S., Peterhoff, C.M., Wolfe, D.M., Martinez-Vicente, M., Massey, A.C., Sovak, G., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141 (2010), 1146–1158.
118. Lee, S., Sato, Y., Nixon, R.A., Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy. Autophagy 7 (2011), 1562–1563.
119. Lee, J.H., McBrayer, M.K., Wolfe, D.M., Haslett, L.J., Kumar, A., Sato, Y., Lie, P.P., Mohan, P., Coffey, E.E., Kompella, U., et al. Presenilin 1 maintains lysosomal Ca(2 + ) homeostasis via TRPML1 by rregulating vATPase-mediated lysosome acidification. Cell Rep. 12 (2015), 1430–1444.
120. Levine, B., Kroemer, G., Autophagy in the pathogenesis of disease. Cell 132 (2008), 27–42.
121. Liberman, R., Bond, S., Shainheit, M.G., Stadecker, M.J., Forgac, M., Regulated assembly of vacuolar ATPase is increased during cluster disruption-induced maturation of dendritic cells through a phosphatidylinositol 3-kinase/mTOR-dependent pathway. J. Biol. Chem. 289 (2014), 1355–1363.
122. Lin, C.H., Tan, E.K., Chen, M.L., Tan, L.C., Lim, H.Q., Chen, G.S., Wu, R.M., Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology 71 (2008), 1727–1732.
123. Liu, J., Lu, W., Reigada, D., Nguyen, J., Laties, A.M., Mitchell, C.H., Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery. Invest. Ophthalmol. Vis. Sci. 49 (2008), 772–780.
124. Lorente-Canovas, B., Ingham, N., Norgett, E.E., Golder, Z.J., Karet Frankl, F.E., Steel, K.P., Mice deficient in H+-ATPase a4 subunit have severe hearing impairment associated with enlarged endolymphatic compartments within the inner ear. Dis. Model Mech. 6 (2013), 434–442.
125. Mahley, R.W., Huang, Y., Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurol. Scand. Suppl. 185 (2006), 8–14.
126. Majumdar, A., Capetillo-Zarate, E., Cruz, D., Gouras, G.K., Maxfield, F.R., Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes. Mol. Biol. Cell 22 (2011), 1664–1676.
127. Malkus, P., Graham, L.A., Stevens, T.H., Schekman, R., Role of Vma21p in assembly and transport of the yeast vacuolar ATPase. Mol. Biol. Cell 15 (2004), 5075–5091.
128. Mangieri, L.R., Mader, B.J., Thomas, C.E., Taylor, C.A., Luker, A.M., Tse, T.E., Huisingh, C., Shacka, J.J., ATP6V0C knockdown in neuroblastoma cells alters autophagy-lysosome pathway function and metabolism of proteins that accumulate in neurodegenerative disease. PLoS One, 9, 2014, e93257.
129. Manuel, T., Sebastian, J., Raquel, S.-V., Victoria, N., Laura, T.-E., Elisabeth, S.-M., Irene, C., Jose Carlos, D., Marisa, V., Antonia, G., et al. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus. Mol. Neurodegener., 7, 2012, 59.
130. Marjuki, H., Gornitzky, A., Marathe, B.M., Ilyushina, N.A., Aldridge, J.R., Desai, G., Webby, R.J., Webster, R.G., Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion. Cell. Microbiol. 13 (2011), 587–601.
131. Marshansky, V., Rubinstein, J.L., Gruber, G., Eukaryotic V-ATPase: novel structural findings and functional insights. Biochim. Biophys. Acta 1837 (2014), 857–879.
132. Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A.C., Mazzulli, J., Mosharov, E.V., Hodara, R., Fredenburg, R., Wu, D.C., Follenzi, A., et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118 (2008), 777–788.
133. Masashi, T., Regina, S., Michael, F., Regulation and isoform function of the V-ATPases. Biochemistry 49 (2010), 4715–4723.
134. Maxfield, F.R., Role of endosomes and lysosomes in human disease. Cold Spring Harbor Perspect. Biol., 6, 2014.
135. Mazzulli, J.R., Xu, Y.H., Sun, Y., Knight, A.L., McLean, P.J., Caldwell, G.A., Sidransky, E., Grabowski, G.A., Krainc, D., Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146 (2011), 37–52.
136. McBrayer, M., Nixon, R.A., Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime. Biochem. Soc. Trans. 41 (2013), 1495–1502.
137. Meikle, P.J., Hopwood, J.J., Clague, A.E., Carey, W.F., Prevalence of lysosomal storage disorders. JAMA 281 (1999), 249–254.
138. Menzies, F.M., Fleming, A., Rubinsztein, D.C., Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 16 (2015), 345–357.
139. Mindell, J.A., Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74 (2012), 69–86.
140. Molin, M., Demir, A.B., Linking peroxiredoxin and Vacuolar-ATPase functions in calorie restriction-mediated life span extension. Int. J. Cell Biol., 2014, 2014, 913071.
141. Morava, E., Lefeber, D.J., Urban, Z., de Meirleir, L., Meinecke, P., Gillessen Kaesbach, G., Sykut-Cegielska, J., Adamowicz, M., Salafsky, I., Ranells, J., et al. Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur. J. Hum. Genet. 16 (2008), 28–35.
142. Morel, N., Neurotransmitter release: the dark side of the vacuolar-H+ ATPase. Biol. Cell. 95 (2003), 453–457.
143. Muench, S.P., Trinick, J., Harrison, M.A., Structural divergence of the rotary ATPases. Q. Rev. Biophys. 44 (2011), 311–356.
144. Nakamura, N., Matsuura, A., Wada, Y., Ohsumi, Y., Acidification of vacuoles is required for autophagic degradation in the yeast, Saccharomyces cerevisiae. J. Biochem. 121 (1997), 338–344.
145. Nakamura, S., Glucose activates H(+)-ATPase in kidney epithelial cells. Am. J. Physiol. Cell Physiol. 287 (2004), C97–105.
146. Nelson, N., Evolution of organellar proton-ATPases. Biochim. Biophys. Acta 1100 (1992), 109–124.
147. Nixon, R.A., Cataldo, A.M., Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J. Alzheimer's disease: JAD 9 (2006), 277–289.
148. Nixon, R.A., Yang, D.-S.S., Autophagy failure in Alzheimer's disease–locating the primary defect. Neurobiol. Dis. 43 (2011), 38–45.
149. Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A., Cuervo, A.M., Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64 (2005), 113–122.
150. Nixon, R.A., Yang, D.-S.S., Lee, J.-H.H., Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4 (2008), 590–599.
151. Nixon, R.A., Niemann-pick type C disease and Alzheimer's disease: the APP-endosome connection fattens up. Am. J. Pathol. 164 (2004), 757–761.
152. Nixon, R.A., The role of autophagy in neurodegenerative disease. Nat. Med. 19 (2013), 983–997.
153. Norgett, E.E., Golder, Z.J., Lorente-Canovas, B., Ingham, N., Steel, K.P., Karet Frankl, F.E., Atp6v0a4 knockout mouse is a model of distal renal tubular acidosis with hearing loss: with additional extrarenal phenotype. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 13775–13780.
154. Pal, R., Bajaj, L., Sharma, J., Palmieri, M., Di Ronza, A., Lotfi, P., Chaudhury, A., Neilson, J., Sardiello, M., Rodney, G.G., NADPH oxidase promotes Parkinsonian phenotypes by impairing autophagic flux in an mTORC1-independent fashion in a cellular model of Parkinson's disease. Sci. Rep., 6, 2016, 22866.
155. Park, J.S., Blair, N.F., Sue, C.M., The role of ATP13A2 in Parkinson's disease: clinical phenotypes and molecular mechanisms. Mov. Disord. 30 (2015), 770–779.
156. Patton, M.A., Tolmie, J., Ruthnum, P., Bamforth, S., Baraitser, M., Pembrey, M., Congenital cutis laxa with retardation of growth and development. J. Med. Genet. 24 (1987), 556–561.
157. Paunescu, T.G., Rodriguez, S., Benz, E., McKee, M., Tyszkowski, R., Albers, M.W., Brown, D., Loss of the V-ATPase B1 subunit isoform expressed in non-neuronal cells of the mouse olfactory epithelium impairs olfactory function. PLoS One, 7, 2012, e45395.
158. Pena-Llopis, S., Brugarolas, J., TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy. Cell Cycle 10 (2011), 3987–3988.
159. Pena-Llopis, S., Vega-Rubin-de-Celis, S., Schwartz, J.C., Wolff, N.C., Tran, T.A., Zou, L., Xie, X.J., Corey, D.R., Brugarolas, J., Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 30 (2011), 3242–3258.
160. Poewe, W.H., Wenning, G.K., The natural history of Parkinson's disease. Ann. Neurol. 44 (1998), S1–9.
161. Polito, V.A., Li, H., Martini-Stoica, H., Wang, B., Yang, L., Xu, Y., Swartzlander, D.B., Palmieri, M., di Ronza, A., Lee, V.M., et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol. Med. 6 (2014), 1142–1160.
162. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997), 2045–2047.
163. Poorkaj, P., Raskind, W.H., Leverenz, J.B., Matsushita, M., Zabetian, C.P., Samii, A., Kim, S., Gazi, N., Nutt, J.G., Wolff, J., et al. A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity. Mov. Disord. 25 (2010), 1409–1417.
164. Porter, K., Nallathambi, J., Lin, Y., Liton, P.B., Lysosomal basification and decreased autophagic flux in oxidatively stressed trabecular meshwork cells: implications for glaucoma pathogenesis. Autophagy 9 (2013), 581–594.
165. Qi, J., Forgac, M., Cellular environment is important in controlling V-ATPase dissociation and its dependence on activity. J. Biol. Chem. 282 (2007), 24743–24751.
166. Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N. Engl. J. Med. 362 (2010), 329–344.
167. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L.P., Goebel, I., Mubaidin, A.F., Wriekat, A.L., Roeper, J., et al. Hereditary Parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38 (2006), 1184–1191.
168. Ramser, J., Abidi, F.E., Burckle, C.A., Lenski, C., Toriello, H., Wen, G., Lubs, H.A., Engert, S., Stevenson, R.E., Meindl, A., et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum. Mol. Genet. 14 (2005), 1019–1027.
169. Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z.W., Jimenez-Sanchez, M., Korolchuk, V.I., Lichtenberg, M., Luo, S., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 90 (2010), 1383–1435.
170. Rawson, S., Phillips, C., Huss, M., Tiburcy, F., Wieczorek, H., Trinick, J., Harrison, M.A., Muench, S.P., Structure of the vacuolar H+-ATPase rotary motor reveals new mechanistic insights. Structure 23 (2015), 461–471.
171. Richo, G.R., Conner, G.E., Structural requirements of procathepsin D activation and maturation. J. Biol. Chem. 269 (1994), 14806–14812.
172. Rigoli, L., Di Bella, C., Wolfram syndrome 1 and Wolfram syndrome 2. Curr. Opin. Pediatr. 24 (2012), 512–517.
173. Rubinsztein, D.C., DiFiglia, M., Heintz, N., Nixon, R.A., Qin, Z.-H.H., Ravikumar, B., Stefanis, L., Tolkovsky, A., Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1 (2005), 11–22.
174. Rubinsztein, D.C., Marino, G., Kroemer, G., Autophagy and aging. Cell 146 (2011), 682–695.
175. Rubinsztein, D.C., The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006), 780–786.
176. Ruckenstuhl, C., Netzberger, C., Entfellner, I., Carmona-Gutierrez, D., Kickenweiz, T., Stekovic, S., Gleixner, C., Schmid, C., Klug, L., Sorgo, A.G., et al. Lifespan extension by methionine restriction requires autophagy-dependent vacuolar acidification. PLoS Genet., 10, 2014, e1004347.
177. Rucker, J.C., Shapiro, B.E., Han, Y.H., Kumar, A.N., Garbutt, S., Keller, E.L., Leigh, R.J., Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS). Neurology 63 (2004), 1918–1926.
178. Ryu, J., Kim, H., Chang, E.J., Kim, H.J., Lee, Y., Kim, H.H., Proteomic analysis of osteoclast lipid rafts: the role of the integrity of lipid rafts on V-ATPase activity in osteoclasts. J. Bone Miner. Metab. 28 (2010), 410–417.
179. Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L., Sabatini, D.M., The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320 (2008), 1496–1501.
180. Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S., Sabatini, D.M., Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141 (2010), 290–303.
181. Sardiello, M., Palmieri, M., di Ronza, A., Medina, D.L., Valenza, M., Gennarino, V.A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R.S., A gene network regulating lysosomal biogenesis and function. Science 325 (2009), 473–477.
182. Saroussi, S., Nelson, N., The little we know on the structure and machinery of V-ATPase. J. Exp. Biol. 212 (2009), 1604–1610.
183. Saroussi, S., Nelson, N., Vacuolar H(+)-ATPase-an enzyme for all seasons. Pflugers Arch. 457 (2009), 581–587.
184. Sautin, Y.Y., Lu, M., Gaugler, A., Zhang, L., Gluck, S.L., Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol. Cell. Biol. 25 (2005), 575–589.
185. Schleit, J., Johnson, S.C., Bennett, C.F., Simko, M., Trongtham, N., Castanza, A., Hsieh, E.J., Moller, R.M., Wasko, B.M., Delaney, J.R., et al. Molecular mechanisms underlying genotype-dependent responses to dietary restriction. Aging Cell 12 (2013), 1050–1061.
186. Schultheis, P.J., Fleming, S.M., Clippinger, A.K., Lewis, J., Tsunemi, T., Giasson, B., Dickson, D.W., Mazzulli, J.R., Bardgett, M.E., Haik, K.L., et al. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation and age-dependent sensorimotor deficits. Hum. Mol. Genet. 22 (2013), 2067–2082.
187. Serrano-Pozo, A., Frosch, M.P., Masliah, E., Hyman, B.T., Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect. Med., 1, 2011, a006189.
188. Sethi, N., Yan, Y., Quek, D., Schupbach, T., Kang, Y., Rabconnectin-3 is a functional regulator of mammalian Notch signaling. J. Biol. Chem. 285 (2010), 34757–34764.
189. Settembre, C., Di Malta, C., Polito, V.A., Garcia Arencibia, M., Vetrini, F., Erdin, S., Erdin, S.U., Huynh, T., Medina, D., Colella, P., et al. TFEB links autophagy to lysosomal biogenesis. Science 332 (2011), 1429–1433.
190. Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A.M., Czaja, M.J., Autophagy regulates lipid metabolism. Nature 458 (2009), 1131–1135.
191. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 2003, 841.
192. Sobacchi, C., Frattini, A., Orchard, P., Porras, O., Tezcan, I., Andolina, M., Babul-Hirji, R., Baric, I., Canham, N., Chitayat, D., et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum. Mol. Genet. 10 (2001), 1767–1773.
193. Spampanato, C., Feeney, E., Li, L., Cardone, M., Lim, J.A., Annunziata, F., Zare, H., Polishchuk, R., Puertollano, R., Parenti, G., et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol. Med. 5 (2013), 691–706.
194. Stefanis, L., Larsen, K.E., Rideout, H.J., Sulzer, D., Greene, L.A., Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 21 (2001), 9549–9560.
195. Steinberg, B.E., Huynh, K.K., Brodovitch, A., Jabs, S., Stauber, T., Jentsch, T.J., Grinstein, S., A cation counterflux supports lysosomal acidification. J. Cell Biol. 189 (2010), 1171–1186.
196. Stover, E.H., Borthwick, K.J., Bavalia, C., Eady, N., Fritz, D.M., Rungroj, N., Giersch, A.B., Morton, C.C., Axon, P.R., Akil, I., et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet. 39 (2002), 796–803.
197. Stransky, L.A., Forgac, M., Amino acid availability modulates vacuolar H+-ATPase assembly. J. Biol. Chem. 290 (2015), 27360–27369.
198. Strom, T.M., Hortnagel, K., Hofmann, S., Gekeler, F., Scharfe, C., Rabl, W., Gerbitz, K.D., Meitinger, T., Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 7 (1998), 2021–2028.
199. Su, Y.C., Qi, X., Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum. Mol. Genet. 22 (2013), 4545–4561.
200. Tiburcy, F., Beyenbach, K.W., Wieczorek, H., Protein kinase A-dependent and -independent activation of the V-ATPase in Malpighian tubules of Aedes aegypti. J. Exp. Biol. 216 (2013), 881–891.
201. Tolar, J., Teitelbaum, S.L., Orchard, P.J., Osteopetrosis. N. Engl. J. Med. 351 (2004), 2839–2849.
202. Torres, M., Jimenez, S., Sanchez-Varo, R., Navarro, V., Trujillo-Estrada, L., Sanchez-Mejias, E., Carmona, I., Davila, J.C., Vizuete, M., Gutierrez, A., et al. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus. Mol. Neurodegener., 7, 2012, 59.
203. Toyomura, T., Murata, Y., Yamamoto, A., Oka, T., Sun-Wada, G.H., Wada, Y., Futai, M., From lysosomes to the plasma membrane: localization of vacuolar-type H+ −ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 278 (2003), 22023–22030.
204. Trombetta, E.S., Ebersold, M., Garrett, W., Pypaert, M., Mellman, I., Activation of lysosomal function during dendritic cell maturation. Science 299 (2003), 1400–1403.
205. Troncoso, J.C., Cataldo, A.M., Nixon, R.A., Barnett, J.L., Lee, M.K., Checler, F., Fowler, D.R., Smialek, J.E., Crain, B., Martin, L.J., et al. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann. Neurol. 43 (1998), 673–676.
206. Urano, F., Wolfram syndrome: diagnosis management, and treatment. Curr. Diab. Rep., 16, 2016, 6.
207. Usenovic, M., Tresse, E., Mazzulli, J.R., Taylor, J.P., Krainc, D., Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J. Neurosci. 32 (2012), 4240–4246.
208. Vavassori, S., Mayer, A., A new life for an old pump: V-ATPase and neurotransmitter release. J. Cell Biol. 205 (2014), 7–9.
209. Vedovelli, L., Rothermel, J.T., Finberg, K.E., Wagner, C.A., Azroyan, A., Hill, E., Breton, S., Brown, D., Paunescu, T.G., Altered V-ATPase expression in renal intercalated cells isolated from B1 subunit-deficient mice by fluorescence-activated cell sorting. Am. J. Physiol. Renal Physiol. 304 (2013), F522–F532.
210. Venzano, V., Conforti, G., Marchesi, A., Minetti, C., Iester, A., The association of juvenile diabetes mellitus, primary optic atrophy and deafness (the Wolfram and Ikkos syndrome). Apropos of a personal case. Minerva Pediatr. 32 (1980), 685–692.
211. Verghese, P.B., Castellano, J.M., Holtzman, D.M., Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10 (2011), 241–252.
212. Wakabayashi, K., Gustafson, A.M., Sidransky, E., Goldin, E., Mucolipidosis type IV: an update. Mol. Genet. Metab. 104 (2011), 206–213.
213. Wang, Y., Floor, E., Hydrogen peroxide inhibits the vacuolar H+-ATPase in brain synaptic vesicles at micromolar concentrations. J. Neurochem. 70 (1998), 646–652.
214. Wang, X., Yan, M.H., Fujioka, H., Liu, J., Wilson-Delfosse, A., Chen, S.G., Perry, G., Casadesus, G., Zhu, X., LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 21 (2012), 1931–1944.
215. Wang, S., Tsun, Z.Y., Wolfson, R.L., Shen, K., Wyant, G.A., Plovanich, M.E., Yuan, E.D., Jones, T.D., Chantranupong, L., Comb, W., et al. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 347 (2015), 188–194.
216. Wienisch, M., Klingauf, J., Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical. Nat. Neurosci. 9 (2006), 1019–1027.
217. Williamson, W.R., Hiesinger, P.R., On the role of v-ATPase V0a1-dependent degradation in Alzheimer disease. Commun. Integr. Biol. 3 (2010), 604–607.
218. Williamson, W.R., Wang, D., Haberman, A.S., Hiesinger, P.R., A dual function of V0-ATPase a1 provides an endolysosomal degradation mechanism in Drosophila melanogaster photoreceptors. J. Cell Biol. 189 (2010), 885–899.
219. Wohlke, A., Philipp, U., Bock, P., Beineke, A., Lichtner, P., Meitinger, T., Distl, O., A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier. PLoS Genet., 7, 2011, e1002304.
220. Wolfe, D.M., Lee, J.-H.H., Kumar, A., Lee, S., Orenstein, S.J., Nixon, R.A., Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur. J. Neurosci. 37 (2013), 1949–1961.
221. Wolfe, D.M., Lee, J.H., Kumar, A., Lee, S., Orenstein, S.J., Nixon, R.A., Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur. J. Neurosci. 37 (2013), 1949–1961.
222. Xiao, Q., Yan, P., Ma, X., Liu, H., Perez, R., Zhu, A., Gonzales, E., Tripoli, D.L., Czerniewski, L., Ballabio, A., et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing abeta generation and amyloid plaque pathogenesis. J. Neurosci. 35 (2015), 12137–12151.
223. Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., Stefanis, L., Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One, 4, 2009, e5515.
224. Xu, Y., Parmar, A., Roux, E., Balbis, A., Dumas, V., Chevalier, S., Posner, B.I., Epidermal growth factor-induced vacuolar (H+)-atpase assembly: a role in signaling via mTORC1 activation. J. Biol. Chem. 287 (2012), 26409–26422.
225. Xue, X., Wang, L.-R.R., Sato, Y., Jiang, Y., Berg, M., Yang, D.-S.S., Nixon, R.A., Liang, X.-J.J., Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease. Nano Lett. 14 (2014), 5110–5117.
226. Yamashiro, D.J., Maxfield, F.R., Acidification of endocytic compartments and the intracellular pathways of ligands and receptors. J. Cell. Biochem. 26 (1984), 231–246.
227. Yang, D.-S.S., Stavrides, P., Mohan, P.S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S.D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain: J. Neurol. 134 (2011), 258–277.
228. Yang, D.-S.S., Stavrides, P., Mohan, P.S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S.D., Wesson, D.W., Bandyopadhyay, U., Jiang, Y., et al. Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy 7 (2011), 788–789.
229. Yang, D.-S.S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J.A., Pawlik, M., Huo, C., Walkley, S.U., Saito, M., Cuervo, A.M., et al. Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits. Brain: J. Neurol. 137 (2014), 3300–3318.
230. Yogendra, S.R., Zoe, H., Ioannis, B., Aging: central role for autophagy and the lysosomal degradative system. Ageing Res. Rev. 8 (2009), 199–213.
231. Yokomakura, A., Hong, J., Ohuchi, K., Oh, S.E., Lee, J.Y., Mano, N., Takahashi, T., Hwang, G.W., Naganuma, A., Increased production of reactive oxygen species by the vacuolar-type (H(+))-ATPase inhibitors bafilomycin A1 and concanamycin A in RAW 264 cells. J. Toxicol. Sci. 37 (2012), 1045–1048.
232. Yuan, Y., Zhang, J., Chang, Q., Zeng, J., Xin, F., Wang, J., Zhu, Q., Wu, J., Lu, J., Guo, W., et al. De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome. Cell Res. 24 (2014), 1370–1373.
233. Zare-Shahabadi, A., Masliah, E., Johnson, G.V., Rezaei, N., Autophagy in Alzheimer's disease. Rev. Neurosci. 26 (2015), 385–395.
234. Zhang, F., Jin, S., Yi, F., Li, P.L., TRP-ML1 functions as a lysosomal NAADP-sensitive Ca2+ release channel in coronary arterial myocytes. J. Cell. Mol. Med. 13 (2009), 3174–3185.
235. Zhang, X., Garbett, K., Veeraraghavalu, K., Wilburn, B., Gilmore, R., Mirnics, K., Sisodia, S.S., A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J. Neurosci. 32 (2012), 8633–8648.
236. Zimmermann, B., Dames, P., Walz, B., Baumann, O., Distribution and serotonin-induced activation of vacuolar-type H+-ATPase in the salivary glands of the blowfly Calliphora vicina. J. Exp. Biol. 206 (2003), 1867–1876.
237. Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., Sabatini, D.M., mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334 (2011), 678–683.
238. van Schalkwyk, D.A., Saliba, K.J., Biagini, G.A., Bray, P.G., Kirk, K., Loss of pH control in Plasmodium falciparum parasites subjected to oxidative stress. PLoS One, 8, 2013, e58933.
239. van Veen, S., Sorensen, D.M., Holemans, T., Holen, H.W., Palmgren, M.G., Vangheluwe, P., Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders. Front. Mol. Neurosci., 7, 2014, 48.